0001415889-25-001117.txt : 20250108
0001415889-25-001117.hdr.sgml : 20250108
20250108160708
ACCESSION NUMBER: 0001415889-25-001117
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250108
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863738787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-93112
FILM NUMBER: 25518599
BUSINESS ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM BioImpact LLC
CENTRAL INDEX KEY: 0001687078
ORGANIZATION NAME:
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: BioImpact Capital LLC
DATE OF NAME CHANGE: 20210831
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001687078
XXXXXXXX
LIVE
Common Stock, par value $0.001 per share
12/31/2024
0001842952 Context Therapeutics Inc. 21077P108
2001 MARKET STREET
SUITE 3915 UNIT #15 PHILADELPHIA
PA
19103
Rule 13d-1(b)
MPM BioImpact LLC
DE
14705882.00
0.00
14705882.00
0.00
14705882.00
16.4
IA
Context Therapeutics Inc.
2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103.
MPM BioImpact LLC 399 Boylston Street, Suite 1100
Boston, MA 02116 Delaware
N
IA
14,705,882 16.4%
14,705,882
0
14,705,882
0
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
MPM BioImpact LLC
Christopher Wolf
Chief Financial Officer
01/07/2025